CLOVER HEALTH INVESTMENTS, CORP. /DE Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $28.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $28.00M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $27.33M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$49.32M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$24.38M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$85.55M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$46.27M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$210.15M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$254.58M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.00M 10-Q · filed 2026-08-07 | $55.34M 10-Q · filed 2026-08-07 | $6.01M derived: sum of 3 quarters · filed 2026-08-07 | -$18.36M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $27.33M 10-Q · filed 2026-05-08 | -$21.99M derived: sum of 2 quarters · filed 2026-05-08 | -$46.36M derived: sum of 3 quarters · filed 2026-05-08 | -$56.94M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$49.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$73.70M derived: sum of 2 quarters · filed 2026-02-27 | -$84.28M derived: sum of 3 quarters · filed 2026-08-07 | -$85.55M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$24.38M 10-Q · filed 2025-11-07 | -$34.95M derived: sum of 2 quarters · filed 2026-08-07 | -$36.23M 10-Q · filed 2025-11-07 | -$57.71M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$10.58M 10-Q · filed 2026-08-07 | -$11.85M 10-Q · filed 2026-08-07 | -$33.33M derived: sum of 3 quarters · filed 2026-08-07 | -$42.12M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$1.27M 10-Q · filed 2026-05-08 | -$22.75M derived: sum of 2 quarters · filed 2026-05-08 | -$31.54M derived: sum of 3 quarters · filed 2026-05-08 | -$24.37M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$21.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$30.27M derived: sum of 2 quarters · filed 2026-02-27 | -$23.10M derived: sum of 3 quarters · filed 2026-02-27 | -$46.27M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$8.79M 10-Q · filed 2025-11-07 | -$1.61M derived: sum of 2 quarters · filed 2025-11-07 | -$24.79M 10-Q · filed 2025-11-07 | -$92.73M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $7.17M 10-Q · filed 2025-08-08 | -$16.00M 10-Q · filed 2025-08-08 | -$83.94M derived: sum of 3 quarters · filed 2026-02-27 | -$117.56M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$23.17M 10-Q · filed 2025-05-09 | -$91.11M derived: sum of 2 quarters · filed 2026-02-27 | -$124.73M derived: sum of 3 quarters · filed 2026-02-27 | -$153.62M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$67.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$101.56M derived: sum of 2 quarters · filed 2026-02-27 | -$130.45M derived: sum of 3 quarters · filed 2026-02-27 | -$210.15M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$33.62M 10-Q · filed 2024-11-08 | -$62.51M derived: sum of 2 quarters · filed 2024-11-08 | -$142.20M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | -$28.89M 10-Q · filed 2024-08-08 | -$108.59M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$79.70M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$254.58M 10-K · filed 2025-03-03 |